Q2 2023 · 13F-HR
GENERAL ATLANTIC, L.P.holdings as filed
Filed 2023-08-11 · accession 0000950142-23-002206
$6.34B
Reported value
30
Positions
2023-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 29283F103 | ESMTUSD | ENGAGESMART | $1.72B | 27.2% | 90,271,540 | Common | SOLE |
| G29018101 | DLO | DLOCAL | $780.0M | 12.3% | 63,906,695 | Common | SOLE |
| 85225A107 | 8DT | SQUARESPACE | $705.3M | 11.1% | 22,361,073 | Common | SOLE |
| G98239109 | XP | XP, INC | $694.8M | 11.0% | 29,617,733 | Common | SOLE |
| 433537107 | — | HIRERIGHT | $363.2M | 5.72% | 32,109,898 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE | $350.7M | 5.53% | 60,993,323 | Common | SOLE |
| 01644J108 | ALKT | ALKAMI | $307.0M | 4.84% | 18,729,806 | Common | SOLE |
| 29882P106 | EWCZ | EUROPEAN WAX CENTER | $244.2M | 3.85% | 13,110,492 | Common | SOLE |
| 60741F104 | MBLY | MOBILEYE | $183.0M | 2.88% | 4,761,905 | Common | SOLE |
| 48576A100 | — | KARUNA THERAPEUTICS | $157.6M | 2.48% | 726,958 | Common | SOLE |
| 18467V109 | YOU | CLEAR SECURE | $112.6M | 1.78% | 4,861,120 | Common | SOLE |
| 00973Y108 | AKRO | AKERO THERAPEUTICS | $83.4M | 1.31% | 1,785,714 | Common | SOLE |
| 26603R106 | DUOL | DUOLINGO | $83.0M | 1.31% | 580,642 | Common | SOLE |
| N69605108 | PHVS | PHARVARIS | $66.7M | 1.05% | 4,406,252 | Common | SOLE |
| 37611X100 | DNA4EUR | GINKGO BIOWORKS | $60.1M | 0.95% | 32,319,896 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS | $59.9M | 0.94% | 9,681,818 | Common | SOLE |
| 45258D105 | IMCR | IMMUNOCORE | $57.0M | 0.90% | 950,000 | Common | SOLE |
| G04553106 | — | ARCO PLATFORM LIMITED | $49.8M | 0.79% | 4,103,366 | Common | SOLE |
| 44842L103 | HCM | HUTCHMED | $48.0M | 0.76% | 4,000,000 | Common | SOLE |
| G7709Q104 | RPRX | ROYALTY PHARMA | $46.1M | 0.73% | 1,500,000 | Common | SOLE |
| 36118L106 | FUTU | FUTU | $44.2M | 0.70% | 1,111,544 | Common | SOLE |
| 00445A100 | — | ACELYRIN | $31.4M | 0.49% | 1,500,000 | Common | SOLE |
| M8216R109 | RSKD | RISKIFIED | $25.9M | 0.41% | 5,324,998 | Common | SOLE |
| 683712103 | OPEN | OPENDOOR | $25.4M | 0.40% | 6,321,519 | Common | SOLE |
| 09352U108 | BLND | BLEND LABS | $18.1M | 0.29% | 19,132,440 | Common | SOLE |
| 88427A107 | — | THIRD HARMONIC BIO | $14.2M | 0.22% | 2,958,762 | Common | SOLE |
| 21077C305 | 5ZZ0 | WISH | $4.0M | 0.06% | 609,615 | Common | SOLE |
| 12430A102 | — | BUZZFEED | $4.0M | 0.06% | 7,862,502 | Common | SOLE |
| 39957D201 | GROV | GROVE COLLABORATIVE | $1.7M | 0.03% | 936,020 | Common | SOLE |
| 005329107 | ADAG | ADAGENE | $390,720 | 0.01% | 264,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.